Have a personal or library account? Click to login
Effects of oral L-arginine supplementation on vasodilation and O2max in male soccer players Cover

Effects of oral L-arginine supplementation on vasodilation and O2max in male soccer players

Open Access
|Mar 2010

References

  1. Adams M. R., C. J. Forsyth, W. Jessup, J. Robinson, D. S. Celermajer (1995) Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J. Am.Coll.Cardiol. 26:1054-1061.
  2. Appleton J. (2002) Arginine: clinical potential of a semiessential amino acid. Altern.Med.Rev. 7:512-522.
  3. Bednarz B, T. Jaxa-Chamiec, J. Gebalska, K. Herbaczynska- Cedro, L. Ceremuzynski (2004) L-arginine supplementation prolongs exercise capacity in congestive heart failure. Kardiol. Pol. 60:348-53.
  4. Bode-Böger S. M., J. Muke, A. Surdacki, G. Brabant, R. H. Böger, J. C. Frölich (2003) Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vascular Med. 8:77-81.10.1191/1358863x03vm474oa
  5. Bode-Böger S. M., R. H. Böger, A. Creutzing, D. Tsikas, F. M. Gutzki (1994) L-Arginine.infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy volunteers. Clin.Sci. 87:303-310.
  6. Bode-Böger S. M., R. H. Böger, A. Galland, D. Tsikas, J. C. Frölich (1998a) L-arginine-induced vasodilation in healthy humans: pharmacokinetics-pharmacodynamic relationship. Br.J. Clin.Pharmacol. 46:489-497.10.1046/j.1365-2125.1998.00803.x
  7. Böger R. H., S. M. Böde-Boger (2001) The clinical pharmacology of L-arginine. Ann.Rev.Pharmacol.Toxicol. 41:79-99.
  8. Ceremuzynski L., T. Chamiec, K. Herbaczynska-Cedro (1997) Effect of supplemental oral arginine on exercise capacity in patients with stable angina pectoris. Am.J. Cardiol. 80: 331-333.10.1016/S0002-9149(97)00354-8
  9. Chin-Dusting J. P. F., C. T. Alexander, P. J. Arnold, W. C. Hodgson, A. S. Lus, G. L. R. Jennings (1996) Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels. J. Cardiovasc.Pharmacol. 28:158-66.
  10. Clarkson P., M. R. Adams, A. J. Powe, A. E. Donald, R. Mc Credie, J. Robinson, S. N. McCarthy, A. Keech, D. S. Celermajer, J. E. Deanfield (1996) Oral L-arginine improves endothelium dependent dilation in hypercholesterolemic young adults. J. Clin. Invest. 97:1989-1994.10.1172/JCI118632
  11. Creager M. A., S. J. Gallagher, X. J. Girerd, S. M. Coleman, V. J. Dzau, J. P. Cooke (1992) L-arginine improves endotheliumdependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90:1248-1253.10.1172/JCI115987
  12. Giugliano D., R. Marfella, L. Coppola, G. Verrazzo, R. Acampora, R. Giunta, F. Nappo (1997) Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95:1783-1790.10.1161/01.CIR.95.7.1783
  13. Giugliano D., R. Marfella, G. Verrazzo, R. Acampora, F. Nappo, P. Ziccardi, L. Coppola (1997) L-arginine for testing endothelium-dependent vascular functions in health and disease. Am.J. Physiol. 273:606-612.
  14. Gornik H. L., M. A. Creager (2004) Arginine and endothelial and vascular health. J. Nutr. 134:2880S-2887S.10.1093/jn/134.10.2880S
  15. Hambrecht R., L. Hilbrich, S. Erbs, S. Gielen, E. Fiehn, N. Schoene, G. Schuler (2000) Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J. Am.Coll.Cardiol. 35:706-713.10.1016/S0735-1097(99)00602-6
  16. Higashi Y., T. Oshima, N. Ono, H. Hiraga, M. Yoshimura, M. Watanabe, H. Matsuura, M. Kambe, G. Kajiyama (1995) Intravenous administration of l-arginine inhibits angiotensin converting enzyme in humans. J. Clin.Endocrinol.Metab. 80:2198-2202.
  17. Huynh N. T., J. A. Tayek (2002) Oral arginine reduces systemic blood pressure in type 2 diabetes: Its potential role in nitric oxide generation. J. Am.Coll.Nutr. 21:422-427.
  18. Lagni Pasini F, C. Frigerio, P. Blardi, L. Domini, L. De Giorgi, G. Borgogni, S. Pecchi, G. Cati, M. Franchi, L. Volpi (1995) Evidence of an adenosine dependent mechanism in the hypotensive effect of L-arginine in man. Clin.Exp.Pharmacol.Physiol. 22:254-259.
  19. Lekakis J. P., S. Papathanassiou, T. G. Papaioannou, C. M. Papamichael, N. Zakopoulos, V. Kotsis, A. G. Dagre, K. Stamatelopoulos, A. Protogerou, S. F. Stamatelopoulos (2002) Oral l-arginine improves endothelial dysfunction in patients with essential hypertension. Int.J. Cardiol. 86:317-323.
  20. Lerman A., J. C. Burnett, S. T. Higano, L. J. McKinley, D. R. Holmes (1998) Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97:2123-2128.10.1161/01.CIR.97.21.2123
  21. Marietta M., F. Facchinetti, I. Neri, F. Piccinini, A. Volpe, G. Torelli (1997) L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release. Thromb.Res. 88:229-235.
  22. Maud P. J., C. Foster (1995) Physiological assessment of human fitness. In: P. J. T Vallance, D. J. Webb (eds) Vascular Endothelium in Human Physiology and Pathophysiology. Human Kinetics, pp. 47-48.
  23. Nagaya N., M. Uematsu, H. Oya, N. Sato, F. Sakamaki, S. Kyotani, K. Ueno, N. Nakanishi, M. Yamagishi, K. Miyatake (2001). Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am.J. Respir.Crit.Care Med. 163:887-891.
  24. Paddon Jones D., E. Borsheim, R. R. Wolfe (2004) Potential ergogenic effects of arginine and creatine supplementation. J. Nutr. 134:10S.10.1093/jn/134.10.2888S15465806
  25. Piatti P. M., L. D. Monti, G. Valsecci, F. Magni, E. Setola, F. Marchesi, M. Gali-Kienle (2001) Long term oral l-arginine administration improves peripheral and hepatic insulin sensivity in type 2 diabetic patients. Diabet.Care 24:875-880.
  26. Rector T. S., A. J. Bank, K. A. Mullen, L. K. Tschumperlin, R. Sih, K. Pillai, S. H. Kubo (1996) Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 93:2135-2141.10.1161/01.CIR.93.12.2135
  27. Rytlewski K., R. Olszanecki, R. Korbut, Z. Zdebski (2005) Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in pre-eclampsia. Eur.J. Clin.Invest. 35:32-37.
  28. Siani A., E. Pagano, R. Iacone, L. Iacoviello, F. Scopacasa, P. Strazzullo (2000) Blood pressure and metabolic changes during dietary l-arginine supplementation in humans. Am.J. Hypertens. 13:547-551.
  29. Sozykin A. V., E. A. Noeva, T. V. Balakhonova, O. A. Pogorelova, M. I. Menshikov (2000) Effect of L-arginine on platelet aggregation, endothelial function and exercise tolerance in patients with stable angina pectoris. Ter.Arkh. 72:24-7.
  30. Williams M. (2005) Dietary supplements and sports performance: amino acids. J. Int.Society Sports Nutr. 2:63-67.10.1186/1550-2783-2-2-63212914818500957
Language: English
Page range: 25 - 29
Published on: Mar 25, 2010
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2010 Hülya Yaman, Gül Tiryaki- Sönmez, Kamil Gürel, published by University of Physical Education in Warsaw
This work is licensed under the Creative Commons License.

Volume 2 (2010): Issue 2010 (January 2010)